Giant Biogene Holding Valuation
Is 2367 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2367?
Other financial metrics that can be useful for relative valuation.
|What is 2367's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 2367's PE Ratio compare to its peers?
|Company||PE||Estimated Growth||Market Cap|
973 L'Occitane International
1044 Hengan International Group
2145 Shanghai Chicmax Cosmetic
6896 Golden Throat Holdings Group
2367 Giant Biogene Holding
Price-To-Earnings vs Peers: 2367 is expensive based on its Price-To-Earnings Ratio (46x) compared to the peer average (26.8x).
Price to Earnings Ratio vs Industry
How does 2367's PE Ratio compare vs other companies in the Asian Personal Products Industry?
Price-To-Earnings vs Industry: 2367 is expensive based on its Price-To-Earnings Ratio (46x) compared to the Asian Personal Products industry average (28.3x)
Price to Earnings Ratio vs Fair Ratio
What is 2367's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||46x|
|Fair PE Ratio||36.6x|
Price-To-Earnings vs Fair Ratio: 2367 is expensive based on its Price-To-Earnings Ratio (46x) compared to the estimated Fair Price-To-Earnings Ratio (36.6x).
Share Price vs Fair Value
What is the Fair Price of 2367 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2367 (HK$36.3) is trading above our estimate of fair value (HK$12.98)
Significantly Below Fair Value: 2367 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
|Date||Share Price||Average 1Y Price Target||Dispersion||High||Low||1Y Actual price||Analysts|
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.